XML 77 R58.htm IDEA: XBRL DOCUMENT v3.20.4
Net Income (Loss) Per Share (Tables)
6 Months Ended
Dec. 31, 2020
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted The following table sets forth the computation of net income (loss) per share for the periods presented:
Three Months Ended
December 31,
Six Months Ended
December 31,
(in thousands, except per share amounts)2020201920202019
Basic:
Numerator:
Net income$90,416 $39,070 $91,253 $37,382 
Less: dividends declared on Series A, B, C & D preferred stock— (86,302)— (86,302)
Less: cumulative dividends on Series D preferred stock— (3,024)— (6,049)
Net income (loss) attributable to common shareholders90,416 (50,256)91,253 (54,969)
Denominator:
Weighted-average common stock outstanding162,645 90,374 162,546 88,945 
Net income (loss) per share—basic:
$0.56 $(0.56)$0.56 $(0.62)
Diluted:
Numerator:
Net income (loss) attributable to common shareholders$90,416 $(50,256)$91,253 $(54,969)
Add: dividends declared on Series A, B & C preferred stock(1)
— — — — 
Add: dividends declared on Series D preferred stock(1)
— — — — 
Add: cumulative dividends on Series D preferred stock(1)
— — — — 
Net income (loss) attributable to common and common equivalent shareholders90,416 (50,256)91,253 (54,969)
Denominator:
Weighted-average common stock outstanding162,645 90,374 162,546 88,945 
Series A, B & C preferred stock outstanding(1)
— — — — 
Series D preferred stock outstanding(1)
— — — — 
Stock options outstanding to purchase shares of common stock(1)
2,918 — 2,831 — 
Total common and common equivalent shares outstanding165,563 90,374 165,377 88,945 
Net income (loss) per share—diluted:
$0.55 $(0.56)$0.55 $(0.62)
__________________
(1)Excluded from the computation of net loss per share-diluted for the three and six months ended December 31, 2019, because the effect would have been anti-dilutive.
The following table sets forth the computation of net (loss) income per share for the years ended June 30:
(in thousands, except per share amounts)202020192018
Basic:
Numerator:
Net income$81,147 $72,579 $34,899 
Less: dividends declared on Series A, B, C & D preferred stock(86,302)(661)(661)
Less: cumulative dividends on Series D preferred stock(10,849)(12,000)(12,000)
Net (loss) income attributable to common shareholders(16,004)59,918 22,238 
Denominator:
Weighted-average common stock outstanding97,496 85,378 81,314 
Net (loss) income per share—basic:
$(0.16)$0.70 $0.27 
Diluted:
Numerator:
Net (loss) income attributable to common shareholders$(16,004)$59,918 $22,238 
Add: dividends declared on Series A, B & C preferred stock(2)
— 181 181 
Add: dividends declared on Series D preferred stock(1)(2)
— 480 — 
Add: cumulative dividends on Series D preferred stock(1)(2)
— 12,000 — 
Net (loss) income attributable to common and common equivalent shareholders(16,004)72,579 22,419 
Denominator:
Weighted-average common stock outstanding97,496 85,378 81,314 
Series A, B & C preferred stock outstanding(2)
— 12,071 12,071 
Series D preferred stock outstanding(1)(2)
— 32,000 — 
Stock options outstanding to purchase shares of common stock(2)
— 3,042 3,036 
Total common and common equivalent shares outstanding97,496 132,491 96,421 
Net (loss) income per share—diluted:
$(0.16)$0.55 $0.23 
__________________
(1)Excluded from the computation of net income per share-diluted for the years ended June 30, 2018 because the effect would have been anti-dilutive.
(2)Excluded from the computation of net income per share-diluted for the years ended June 30, 2020 because the effect would have been anti-dilutive.
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share
The number of outstanding anti-dilutive shares that were excluded from the computation of diluted net income (loss) per share consisted of the following for the periods presented:
Three Months Ended
December 31,
Six Months Ended
December 31,
(in thousands)2020201920202019
Series A, B & C preferred stock outstanding— 12,071 — 12,071 
Series D preferred stock outstanding— 32,000 — 32,000 
Stock options outstanding to purchase shares of common stock— 3,845 — 4,908 
Total
— 47,916 — 48,979 
The number of outstanding anti-dilutive shares that were excluded from the computation of diluted net loss per share consisted of the following as of June 30:
(in thousands)202020192018
Series A, B & C preferred stock outstanding10,871 — — 
Series D preferred stock outstanding28,817 — 32,000 
Series E preferred stock outstanding694 — — 
Stock options outstanding to purchase shares of common stock4,161 — — 
Total
44,543 — 32,000